Imiquimod 5% cream in the treatment of Bowen's disease

Journal of the American Academy of Dermatology

Volumn 44, Issue 3, 2001, Pages 462-470

  Mackenzie Wood, Andrew ^a   Kossard, Steven ^a   De Launey, John ^a   Wilkinson, Barbara ^a   Owens, Mary L ^b  

^a SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^b 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT;

ADULT; AGED; ARTICLE; BOWEN DISEASE; CLINICAL TRIAL; CREAM; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0035102498     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.111335     Document Type: Article

References (29)

1. Inhibition of murine tumor growth by an interferon inducing imidazoquinolinamine
2. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression
3. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers, imiquimod and S-28463
4. A randomised, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
5. Self-administered topical 5% imiquimod cream for external anogenital warts
6. Cutaneous Bowen's disease: An analysis of 1001 cases according to age, sex, and site
7. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii: A population-based incidence report
8. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation
9. Cutaneous late manifestations in former mustard gas workers
10. Bowenoid papulosis: A clinicopathologic study with ultrastructural observations
11. The presence of mucosal human papillomavirus in Bowen's disease of the hands
12. A novel human papillomavirus identified in epidermodysplasia verruciformis
13. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients
14. Detection of human papillomavirus in extragenital Bowen's disease using in situ hybridization and polymerase chain reaction
15. Carcinoma arising in Bowen's disease
16. Bowen's disease: Statistical study of a 10 year period
17. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant lesions
18. Bowen's disease of the distal digit outcome of treatment with carbon dioxide laser vaporization
19. Large patches of Bowen's disease treated with topical aminolaevulinic acid photodynamic therapy
20. Bowen's disease and 5-fluorouracil
21. 5-Fluorouracil iontophoretic therapy for Bowen's disease
22. Efficacy of interferons on bowenoid papulosis and other precancerous lesions
23. Treatment of multiple lesions of Bowen's disease with isotretinoin and interferon alfa: Efficacy of combination chemotherapy
24. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients
25. A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily
26. Imiquimod: In vivo and in vitro characteristics and toxicology
27. Partial spontaneous regression of Bowen's disease
28. Characterization of the mononuclear infiltrate in Bowen's disease (squamous cell carcinoma in situ): Evidence for a T cell-mediated anti-tumor immune response
29. Characterization of the mononuclear infiltrate in basal cell carcinoma: A predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells